← Back to Clinical Trials
Recruiting NCT06780995

NCT06780995 Power Exercise for Stroke Recovery: The POWER Pilot Trial (POWER-P)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06780995
Status Recruiting
Phase —
Sponsor McMaster University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-09-15
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Power Exercise for Stroke Recovery (POWER)Strength Training Engaging Guidelines to Enhance Total Health (STRENGTH)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-09-15 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Weakness is one of the most common consequences of stroke. For the over 750,000 Canadians living with stroke, many daily activities like standing from a chair, walking and balance not only require strength but often efforts in bursts, known as muscle power. Strength training can improve muscle strength and, when performed at higher speeds, can help build muscle power. Current guidelines for stroke recommend strength training but these are commonly performed at lower intensities and do not include any focus on building muscle power. There has been very little research on power training after stroke. A 10-week power training program for people living with stroke, Power Exercise for Stroke Recovery (POWER-Feasibility, NCT05816811) was recently evaluated. POWER includes 3 phases of progressive exercise: building familiarity with the upper and lower body exercises, then strength, and lastly muscle power. The results from POWER-Feasibility are promising, suggesting that POWER is safe and may improve stroke recovery. POWER-Feasibility was a small study (15 participants), and POWER was not compared to a control intervention. A pilot randomized controlled trial of POWER (POWER-Pilot) will now be conducted. Sixty people who are at least 6 months after stroke will be recruited. They will be randomly assigned to participate in POWER or standard strength training for stroke at lower intensities and without focus on power training. The feasibility of a randomized study will be examined, and whether POWER can improve walking, strength and balance compared to the control group. Results from POWER-Pilot will help design a larger randomized trial in the future (POWER-RCT), and may ultimately be important for stroke rehabilitation teams to better understand whether power training can help people recovering from stroke.

Eligibility Criteria

Inclusion Criteria: 1. ≥19 years old 2. ≥6 months poststroke, 3. able to walk \>10 meters with or without an assistive device 4. have mild to moderate stroke severity (modified Rankin Scale ≤3) 5. without significant cognitive impairment that would preclude safe exercise, screened via Montreal Cognitive Assessment-Blind score \<18 Exclusion Criteria: 1. Any contraindications to exercise for people with cardiovascular disease, such as unstable angina, uncontrolled hypertension, orthostatic blood pressure with exercise, or uncontrolled arrhythmias or 2. Actively engaged in or have made plans to engage in stroke rehabilitation services

Contact & Investigator

Central Contact

Ada Tang, PT PhD

✉ atang@mcmaster.ca

📞 289-426-5768

Frequently Asked Questions

Who can join the NCT06780995 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06780995 currently recruiting?

Yes, NCT06780995 is actively recruiting participants. Contact the research team at atang@mcmaster.ca for enrollment information.

Where is the NCT06780995 trial being conducted?

This trial is being conducted at Kelowna, Canada, Hamilton, Canada.

Who is sponsoring the NCT06780995 clinical trial?

NCT06780995 is sponsored by McMaster University. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology